Bruker announced that it has appointed Gerald N. Herman to serve as the company's Interim Chief Financial Officer (CFO), effective as of March 17, 2018. Mr. Herman was recently also appointed as company's Principal Accounting Officer (PAO), and he will assume his additional responsibilities as Interim CFO upon the departure of current CFO Anthony L. Mattacchione, whose resignation was announced in February 2018. Prior to joining Bruker, Mr. Herman had served in senior executive positions with various publicly traded companies, including as Corporate Vice President - Clinical Operations of PAREXEL International from 2014 to February 2016, and as Corporate Vice President & Controller- Finance of PAREXEL from 2008 to 2013.